By
AmyT on
August 23, 2010
My Spring post on the new injectable type 2 diabetes drug Victoza is in the running for one of the most-commented-ever blog posts here at the ‘Mine. Over 100 people now taking the medication have chimed in.
Victoza, for the unfamiliar, is a new once-daily form of the new-generation GLP-1 drugs that stimulate pancreas cells to release insulin in people with type 2 diabetes. It’s a head-to-head competitor with the injectable drug Byetta, and both…
Read more »
Novo Nordisk is well-known in the diabetes community for its insulins, Novolog and Levemir, used to treat mainly type 1 diabetes. But in the last year, Novo launched a new kind of injectable, a “first line of defense for people with type 2 diabetes” called Victoza (generic: liraglutide). It’s a glucagon-like peptide-1 (GLP-1) drug designed to stimulate insulin secretion when hyperglycemia (high blood sugar) is present.
Victoza is still the new kid on the block…
Read more »
It’s not every day that you pick up a diabetes book with an ice cream cone on the cover — or two, actually! (OK, one is squashed) But the new book by fellow Type 1 D-writer and advocate Riva Greenberg is something different in many ways.
There are numerous books that aim to dispel myths about diabetes, of course. But Riva’s “50 Diabetes Myths That Can Ruin Your Life and the 50 Diabetes Truths That…
Read more »
Considering what I am about to write, I feel a little guilty about the post headline here. But these sensational headlines are just the point: the media is abuzz the last few days with the possibility that Lantus insulin “may be linked” to cancer.
The rumors started late last week, when the media got wind that a prominent diabetes researcher forecasted that an “earthquake” event was about to hit that would compromise the safety profile…
Read more »
By
AmyT on
December 22, 2008
It’s that time again. Another year has passed, and one can’t help wondering: was there any significant progress made in the diabetes world? I guess if you only count “progess” as steps towards a cure, that’s a difficult question to answer. For what it’s worth, here’s my own list of milestone events that occurred this year:
♦ The ACCORD study results were announced, and interpreted to sound like tight blood glucose control might kill you…
Read more »
